Consistent with these findings, our results showed that disruption of Notch1 signaling in Foxo1-deficient livers increased cGAS and STING activation, leading to exacerbated hepatic steatosis, fibrosis, and inflammation. Here, NOTCH1 is linked to fatty liver disease.